Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
HealthCare Royalty Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
HealthCare Royalty Partners

HealthCare Royalty Partners

Operating

HealthCare Royalty Partners: A global private equity firm investing in healthcare and biotech royalties.

Location
Stamford, CT, US
Founded
2007
Firm
Compare
Portfolio
Fundraising
Employees

HealthCare Royalty Partners, L.P. operates as a private equity firm. The Company seeks to invest in royalty rights of healthcare, pharmaceutical, therapeutic devices, and biotechnology companies.

HealthCare Royalty Partners operates in the United States, Europe, and Asia.

HealthCare Royalty Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments15
Current Portfolio Count10
Total Portfolio Exits1

Top Investment Stages

Post Ipo Debt6 (46.2%)
Private Equity3 (23.1%)
Public2 (15.4%)
Debt Financing1 (7.7%)
Series B1 (7.7%)

Stage Mix

Post Ipo Debt 46%Private Equity 23%Public 15%Debt Financing 8%Series B 8%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Liquidia logo

Liquidia

Cara Therapeutics logo

Cara Therapeutics

Clearside Biomedical logo

Clearside Biomedical

Ardelyx logo

Ardelyx

Rhythm Pharmaceuticals logo

Rhythm Pharmaceuticals

Spero Therapeutics logo

Spero Therapeutics

Coherus BioSciences logo

Coherus BioSciences

Helomics logo

Helomics

AcuFocus logo

AcuFocus

Nuron Biotech logo

Nuron Biotech

Suneva Medical logo

Suneva Medical

HealthCare Royalty Partners - Classification

Also Known As
  • Healthcare Royalty, Inc.
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 27 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 520000Finance and Insurance
  • 620000Health Care and Social Assistance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 523900Other Financial Investment Activities
  • 541700Scientific Research and Development Services
  • 523940Portfolio Management and Investment Advice
  • 523990All Other Financial Investment Activities
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 6720Investment Offices
  • 6790Miscellaneous Investing
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 6722Management Investment Offices, Open-end
  • 6799Investors, Not Elsewhere Classified
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research